Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
The aim of this study was to first evaluate whether the chitosan hydrochloride-genipin crosslinking reaction is influenced by factors such as time, and polymer/genipin concentration, and second, to develop crosslinked drug loaded microspheres to improve the control over drug release. Once the crosslinking process was characterized as a function of the factors mentioned above, drug loaded hydrochloride chitosan microspheres with different degrees of crosslinking were obtained. Microspheres were characterized in terms of size, morphology, drug content, surface charge and capacity to control in vitro drug release. Clarithromycin, tramadol hydrochloride, and low molecular weight heparin (LMWH) were used as model drugs. The obtained particles were spherical, positively charged, with a diameter of 1–10 μm. X-Ray diffraction showed that there was an interaction of genipin and each drug with chitosan in the microspheres. In relation to the release profiles, a higher degree of crosslinking led to more control of drug release in the case of clarithromycin and tramadol. For these drugs, optimal release profiles were obtained for microspheres crosslinked with 1 mM genipin at 50 ºC for 5 h and with 5 mM genipin at 50 ºC for 5 h, respectively. In LMWH microspheres, the best release profile corresponded to 0.5 mM genipin, 50 ºC, 5 h. In conclusion, genipin showed to be eligible as a chemical-crosslinking agent delaying the outflow of drugs from the microspheres. However, more studies in vitro and in vivo must be carried out to determine adequate crosslinking conditions for different drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The disappearance of TrH diffraction peaks suggests a loss of crystallinity, indicating that TrH exists in an amorphous or molecularly dispersed state within the polymeric matrix.51,52”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chitosan microspheres as a potential carrier for drugs
Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., & Dhawan, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.026 · Cited by 1,128 · cited 1×
“This is in accordance with a high number of studies that revealed the fastest drug release from chitosan microspheres at the initial release stages [19].”
ResultGenipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids
Muzzarelli, R. A. A. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.01.016 · Cited by 733 · cited 1×
“Its aglycone, genipin (Figure 1), has recently attracted much interest as a crosslinking agent for biomedical use because of its biocompatibility and because it forms stable and biocompatible crosslinked products [4,5].”
BackgroundButler, M. F., Ng, Y., & Pudney, P. D. A. (2003) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.10960 · Cited by 647 · cited 3×
“The formation of crosslinks between genipin and primary amine groups [5] and the finding that genipin-crosslinked networks are significantly less cytotoxic than those crosslinked by glutaraldehyde [6] prompted us to use this chemical as a crosslinking agent to develop chitosan microspheres for controlled drug release.”
BackgroundSung, H.-W., Huang, R.-N., Huang, L. L. H., & Tsai, C.-C. (1999) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856299x00289 · Cited by 506 · cited 1×
“Genipin reacts with compounds containing primary amine groups, such as chitosan and some peptides and polypeptides, to form covalently crosslinked networks [7–10].”
BackgroundChitosan microspheres prepared by spray drying
He, P. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00125-8 · Cited by 479 · cited 1×
“LMWH loaded microspheres crosslinked with genipin show an X-ray diffraction pattern with no marked peaks, which indicates that the crosslinking agent is molecularly dispersed in the polymer matrix [14,15], which should help to retard the delivery of the drug [16].”
BackgroundCell microencapsulation technology: Towards clinical application
Murua, A., Portero, A., Orive, G., Hernández, R. M., de Castro, M., & Pedraz, J. L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.010 · Cited by 333
Mi, F.-L., Sung, H.-W., & Shyu, S.-S. (2002) · Carbohydrate Polymers · doi:10.1016/s0144-8617(01)00212-0 · Cited by 332 · cited 1×
“Genipin reacts with compounds containing primary amine groups, such as chitosan and some peptides and polypeptides, to form covalently crosslinked networks [7–10].”
BackgroundMi, F., Shyu, S., & Peng, C. (2005) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.20669 · Cited by 313 · cited 1×
“co-workers proposed [20], polymerized genipin chains could lead to wider nets in the microsphere matrix and, as a consequence, to less control in drug release.”
BackgroundAntiinflammatory effects of genipin, an active principle of gardenia
Koo, H.-J., Song, Y. S., Kim, H.-J., Lee, Y.-H., Hong, S.-M., Kim, S.-J., Kim, B.-C., Jin, C., Lim, C.-J., & Park, E.-H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.031 · Cited by 311 · cited 1×
“Geniposide is extracted from the fruit of Gardenia jasminoides Ellis, traditionally used in oriental medicine for the treatment of inflammation, headache, and hepatic disorders among others [3].”
BackgroundThe effect of cross-linking of chitosan microspheres with genipin on protein release
Yuan, Y., Chesnutt, B. M., Utturkar, G., Haggard, W. O., Yang, Y., Ong, J. L., & Bumgardner, J. D. (2007) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.10.023 · Cited by 296 · cited 1×
“However, there are concerns over the toxicity of the most studied cross-linking agents, especially glutaraldehyde, which may impair the biocompatibility of the chitosan delivery system [2], and therefore, there is a need to provide a crosslinking agent that has low cytotoxicity.”
Background
Research works printed but not linked: 1
- Lambert, JB (1998). Organic Strutural Spectroscopy, Prentice Hall International Ltd.
Cited by
Chitosan based hydrogels and their applications for drug delivery in wound dressings: A review
Hamedi, H., Moradi, S., Hudson, S. M., & Tonelli, A. E. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.06.114 · Cited by 759
Why Chitosan? From properties to perspective of mucosal drug delivery
Kumar, A., Vimal, A., & Kumar, A. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.05.054 · Cited by 240
Martins, A. F., de Oliveira, D. M., Pereira, A. G. B., Rubira, A. F., & Muniz, E. C. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.08.032 · Cited by 168
Liu, Y., Cai, Z., Sheng, L., Ma, M., Xu, Q., & Jin, Y. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.04.001 · Cited by 159
Manickam, B., Sreedharan, R., & Elumalai, M. (2014) · Current Drug Delivery · doi:10.2174/15672018113106660059 · Cited by 138
Wu, S.-J., Don, T.-M., Lin, C.-W., & Mi, F.-L. (2014) · Marine Drugs · doi:10.3390/md12115677 · Cited by 127
“Chitosan (CS), a linear polysaccharide obtained by partial deacetylation of chitin, has been widely used in the biomedical field and drug delivery applications [12–14].”
BackgroundShah, B., Khunt, D., Misra, M., & Padh, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.076 · Cited by 112
In vitro evaluation of the biodegradability of chitosan–genipin hydrogels
Reay, S. L., Jackson, E. L., Ferreira, A. M., Hilkens, C. M. U., & Novakovic, K. (2022) · Materials Advances · doi:10.1039/d2ma00536k · Cited by 109
Skop, N. B., Calderón, F. H., Levison, S. W., Gandhi, C. D., & Cho, C. H. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.02.043 · Cited by 109
Pahlevanzadeh, F., Emadi, R., Valiani, A., Kharaziha, M., Poursamar, S. A., Bakhsheshi‐Rad, H. R., Ismail, A. F., Ramakrishna, S., & Berto, F. (2020) · Materials · doi:10.3390/ma13112663 · Cited by 104
“In the current scientific studies, genipin (GE) has typically substituted cross-linkers including glutaraldehyde to fabricate cross-linked CS for biomedical purposes because of the positive aspects including cytocompatibility, great chemistry and remaining less cytotoxic in comparison with glutaraldehyde, and pharmaco…”
BackgroundJavanbakht, S., Shadi, M., Mohammadian, R., Shaabani, A., Amini, M. M., Pooresmaeil, M., & Salehi, R. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101311 · Cited by 73
Genipin Cross-Linked Nanocomposite Films for the Immobilization of Antimicrobial Agent
Khan, A., Salmieri, S., Fraschini, C., Bouchard, J., Riedl, B., & Lacroix, M. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am503564m · Cited by 72
Nayak, S., Dey, S., & Kundu, S. C. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.01.042 · Cited by 54
Selvakumaran, S., & Muhamad, I. I. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.005 · Cited by 51
Du, J. R., Hsu, L. H., Xiao, E. S., Guo, X. M., Zhang, Y., & Feng, X. (2020) · Separation and Purification Technology · doi:10.1016/j.seppur.2020.116843 · Cited by 50
Ethyl cellulose nanoparticles: Clarithomycin encapsulation and eradication of H. pylori
Pan-In, P., Banlunara, W., Chaichanawongsaroj, N., & Wanichwecharungruang, S. P. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.025 · Cited by 48
Khatun, B., Banik, N., Hussain, A., Ramteke, A. S., & Maji, T. K. (2018) · Journal of Microencapsulation · doi:10.1080/02652048.2018.1524524 · Cited by 46
“Similarly, at a fixed MMT content, the encapsulation efficiency of nanoparticles was further decreased with the increase in genipin concentration due to restricted motion of the polymer chains which assist the formation of porous structure (Harris et al. 2010).”
BackgroundIannone, M., Mare, R., Paolino, D., Gagliardi, A., Froiio, F., Cosco, D., & Fresta, M. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.022 · Cited by 43
Fernández‐Lucas, J., Harris, R., Casar, I. M., Heras, Á., de la Mata, I., & Arroyo, M. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1304-4 · Cited by 40
Self-citationShen, S., Fu, D., Xu, F., Long, T., Hong, F., & Wang, J. (2013) · Biomedical Materials · doi:10.1088/1748-6041/8/2/025007 · Cited by 40
Neto, B., da Mata, A. L. M. L., Lopes, M. V., Rossi‐Bergmann, B., & Ré, M. I. (2013) · Powder Technology · doi:10.1016/j.powtec.2013.10.046 · Cited by 38
Winotapun, W., Opanasopit, P., Ngawhirunpat, T., & Rojanarata, T. (2013) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2013.05.001 · Cited by 37
Karam, T. K., Ortega, S., Ueda‐Nakamura, T., Auzély‐Velty, R., & Nakamura, C. V. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.149 · Cited by 35
Swelling behaviour and glass transition in genipin-crosslinked chitosan systems
Whitehead, F. A., Young, S. A., & Kasapis, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.08.178 · Cited by 35
Ghasemzadeh, H., Mahboubi, A., Karimi, K., & Samaneh, H. (2016) · Polymers for Advanced Technologies · doi:10.1002/pat.3785 · Cited by 33
Darvishi, S., Hosseinzadeh, H., Kazeminava, F., Mahoutforoush, A., Tajik, M., Rasoulzadehzali, M., Mohammadi, R., Sadjadi, S., & Javanbakht, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136648 · Cited by 34
Chen, R., Cai, X., Ma, K., Zhou, Y., Wang, Y., & Jiang, T. (2017) · Biofabrication · doi:10.1088/1758-5090/aa70c3 · Cited by 33
Song, T.-H., Jang, J., Choi, Y., Shim, J., & Cho, D. (2015) · Cell Transplantation · doi:10.3727/096368915x686779 · Cited by 31
Crosslinked gelatin hydrogels as carriers for controlled heparin release
Gritsch, L., Motta, F. L., Negrini, N. C., Yahia, L., & Farè, S. (2018) · Materials Letters · doi:10.1016/j.matlet.2018.06.047 · Cited by 30
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation
Ventura, C. A., Cannavà, C., Stancanelli, R., Paolino, D., Cosco, D., Mantia, A. L., Pignatello, R., & Tommasini, S. (2011) · Biomedical Microdevices · doi:10.1007/s10544-011-9550-6 · Cited by 30
“2(a)), probably as a result of rapid particle shrinking during the drying process (Harris et al. 2010).”
BackgroundDing, Y., Hou, J., Zhang, Y., Zhang, L., Zhang, T., Chen, Y., Cai, Z., & Yang, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/957030 · Cited by 30
Parker, A. C., Jennings, J. A., Bumgardner, J. D., Courtney, H. S., Lindner, E., & Haggard, W. O. (2012) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32822 · Cited by 31
Noureen, S., Noreen, S., Ghumman, S. A., Batool, F., Hameed, H., Hasan, S., Noreen, F., Elsherif, M. A., & Bukhari, S. N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050916 · Cited by 28
“These results proposed that the drug remained in its amorphous form in the polymer matrix [85,86].”
BackgroundKamguyan, K., Torp, A. M., Christfort, J. F., Guerra, P. R., Licht, T. R., Nielsen, L. H., Zór, K., & Boisen, A. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01333 · Cited by 28
Kamguyan, K., Kjeldsen, R. B., Moghaddam, S. Z., Nielsen, M. R., Thormann, E., Zór, K., Nielsen, L. H., & Boisen, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112536 · Cited by 23
Do, M., Im, B., Park, J. P., Jang, J., & Lee, H. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702017 · Cited by 24
Novel use of biodegradable casein conduits for guided peripheral nerve regeneration
Hsiang, S.-W., Tsai, C., Tsai, F., Ho, T., Yao, C., & Chen, Y.-S. (2011) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0009 · Cited by 23
“1982) was crosslinked by genipin, which is a naturally occurring and low-cytotoxic crosslinking agent that can be obtained from its parent compound geniposide isolated from the fruits of Gardenia jasminoides ELLIS (Chen et al. 2005; Bispo et al. 2010; Harris et al. 2010).”
BackgroundStructural relaxation and glass transition in high-solid gelatin systems crosslinked with genipin
Whitehead, F. A., Young, S. A., & Kasapis, S. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.030 · Cited by 23
Shimojo, A. A. M., Galdames, S. E. M., Perez, A. G. M., Ito, T. H., Luzo, Â. C. M., & Santana, M. H. A. (2016) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-015-9111-9 · Cited by 22
Vila-Sanjurjo, C., Hembach, L., Netzer, J., Remuñán‐López, C., Vila‐Sanjurjo, A., & Goycoolea, F. M. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.05.075 · Cited by 21
Genipin-enriched chitosan-Zein nanoparticles for improved curcumin encapsulation
Sha, L., Raza, H., Jia, C., Khan, I. M., Yang, H., & Chen, G. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138555 · Cited by 22
Zhang, Y., Yu, Y., Shi, X., Zhao, S., Chen, A., Huang, D., Niu, D., & Qin, Z. (2013) · Journal of Polymer Research · doi:10.1007/s10965-013-0175-8 · Cited by 20
Thermosensing mechanisms and their impairment by high-fat diet in orexin neurons
Belanger‐Willoughby, N., Linehan, V., & Hirasawa, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.003 · Cited by 19
Zhou, J., Chen, Y., Luo, M., Fen, D., Lin, S., Wu, W., Li, G., & Nan, K. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1569025 · Cited by 18
Kaufmann, G., Klein, M. P., Goettert, M. I., & Aguirre, T. A. S. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111649 · Cited by 20
Genipin Cross-Linking of Elastin and Elastin-Based Proteins
Muiznieks, L. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7893-9_17 · Cited by 14
Encinas-Basurto, D., Ruiz, V. H., Schnellmann, R. G., & Mansour, H. M. (2025) · Gels · doi:10.3390/gels11050312 · Cited by 14
“Similar biphasic release behavior has been seen with genipin-crosslinked chitosan matrices containing polyanionic drugs, with a quick burst release followed by an extended gradual release phase extending more than 20 h [35].”
Opioid-based micro and nanoparticulate formulations: alternative approach on pain management
Pedro, A. S., Santo, R. F. D. E., Villarreal, C. F., Fialho, R. L., & Albuquerque, E. C. D. M. C. (2016) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1134687 · Cited by 13
“The use of crosslinkers modulates the particle porosity reducing the drug release (Harris et al., 2010).”
BackgroundRamburrun, P., Choonara, Y. E., Kumar, P., du Toit, L. C., & Pillay, V. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.059 · Cited by 12
“…matrices (Pasparakis and Bouropoulos, 2006; Srinatha et al., 2008; Kotadiya et al., 2009; Yang et al., 2011; Ko et al., 2002; Lin et al., 2005; Harris et al., 2010; Jonassen et al., 2012; Rampino et al., 2013) comprise chitosan alone or blended with other property-modifying natural or…”
BackgroundFunctional finishing of aminated polyester using biopolymer‐based polyelectrolyte microgels
Glampedaki, P., Dutschk, V., Jocić, D., & Warmoeskerken, M. M. C. G. (2011) · Biotechnology Journal · doi:10.1002/biot.201100115 · Cited by 12
Ding, Y., Zhang, T., Jian-sheng, T., Tan, B., Guo, C., & Yang, L. (2011) · Biomedical Chromatography · doi:10.1002/bmc.1735 · Cited by 11
Potential Applications of Chitosan as a Marine Cosmeceutical
Lima, E., Muñoz, L. E. Í., Harris, R., & Caballero, A. H. (2011) · CRC Press eBooks · doi:10.1201/b10120-25 · Cited by 13
Self-citationVila-Sanjurjo, C., David, L., Remuñán‐López, C., Vila‐Sanjurjo, A., & Goycoolea, F. M. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2019.08.061 · Cited by 11
Chitosan-genipin nanohydrogel as a vehicle for sustained delivery of alpha-1 antitrypsin.
Ghasemi, A., Mohtashami, M., Sheijani, S. S., & Aliakbari, K. (2015) · Europe PMC (PubMed Central) · Cited by 11
Wang, J., Lin, Q., Qiu, C., McClements, D. J., Ji, H., & Jin, Z. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122789 · Cited by 9
Aydınoğlu, D., & Ünal, M. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2018.1525545 · Cited by 9
Shi, Z., Huang, G., Li, Z., Lou, Z., Gong, Z., Wang, X., Li, C., & Wang, B. (2023) · Materials Advances · doi:10.1039/d3ma00109a · Cited by 8
Mahoutforoush, A., Rasoulzadehzali, M., Ashrafi, E., Tajik, M., Golpayegani, E., Mehramiz, M., Hamishehkar, H., Kazeminava, F., & Javanbakht, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148115 · Cited by 7
Winotapun, W., Kongpakwattana, K., Dejpittayanunt, S., Pathomcharoensukchai, S., Suksaran, U., Nuntharatanapong, N., & Rojanarata, T. (2012) · Talanta · doi:10.1016/j.talanta.2012.07.084 · Cited by 7
Carbohydrate-based alternatives to traditional synthetic plastic microbeads: a critical review
McMackin, A., & Cardinal, S. (2025) · RSC Sustainability · doi:10.1039/d4su00364k · Cited by 8
Xu, J., Li, W., Liu, Z., Li, J., Zhao, X., Li, D., Guo, S., & Zhang, X. (2015) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-015-0261-x · Cited by 6
“Previous microsphere works are mostly related with in vivo H. pylori clearance effect of CLA (Chun et al. 2005; Jain and Jangdey 2009) and control release (Harris et al. 2010).”
BackgroundGenipin-cross-linked poly(vinyl alcohol) for neural scaffold
Alhosseini, S. N., Moztarzadeh, F., & Karkhaneh, A. (2017) · Bioinspired Biomimetic and Nanobiomaterials · doi:10.1680/jbibn.16.00043 · Cited by 4
Darvishi, S., Sadjadi, S., Monflier, É., & Heravi, M. M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142560 · Cited by 4
Javanbakht, S., & Mohammadi, R. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100403 · Cited by 3
“2B. ChS exhibited a broad peak around 22 ◦ , indicative of its amorphous nature (Harris et al., 2010).”
Jhang, J., Lin, J., & Chen, Y.-S. (2021) · Journal of Applied Polymer Science · doi:10.1002/app.50763 · Cited by 3
Unravelling the molecular network structure of biohybrid hydrogels
Sievers, J., Dockhorn, R., Friedrichs, J., Kurth, T., Fratzl, P., Sommer, J., Werner, C., & Freudenberg, U. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102249 · Cited by 4
“The heparin powder exhibits a broad, amorphous peak typical of dehydrated polymers [44], whereas PEG polymers normally display distinct, narrow peaks in WAXS indicative of crystalline domains [45 – 47].”
Terminalia arjuna gum as a novel biopolymer for microbead formulation in pH-sensitive drug delivery
Basharat, M., Noreen, S., Khan, A., Anwar, F., Ijaz, B., Munawar, K. S., Anwar, M., & Abdullah, M. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2531402 · Cited by 2
Serrano-Castañeda, P., Escobar‐Chávez, J. J., Morales-Hipólito, E. A., Domínguez-Delgado, C. L., & Abrego, V. H. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Kouřil, J., Vysloužil, J., Kejdušová, M., Dvořáčková, K., & Vetchý, D. (2014) · Česká a slovenská farmacie · doi:10.36290/csf.2014.015 · Cited by 2
Payasi, M., Bhowmick, M., Pandey, G. K., Joshi, A., & Dubey, B. (2013) · International Journal of Biomedical and Advance Research · doi:10.7439/ijbar.v4i10.553 · Cited by 2
Study on the Preparation of Repaglinide Chitosan Microspheres with Genipin
Zhang, Y., Shi, X., Yu, Y., & Song, Y. X. (2013) · Advanced materials research · doi:10.4028/www.scientific.net/amr.791-793.252 · Cited by 1
InFiQuS: Making the Best of Leftovers
Aranaz, I., Acosta, N., Mengíbar, M., Calderón, L., Harris, R., & Heras, Á. (2016) · Wiley eBooks · doi:10.1002/9781118843796.ch15 · Cited by 1
Self-citationHajjali, H. (2015) · theses.fr (ABES) · doi:10.70675/6a77e8fdzbf94z47dcz83d4z1453af47a4ef · Cited by 1
Noureen, S., Noreen, S., Batool, F., Ghumman, S. A., Hasan, S., Aslam, S., & Ahmed, N. (2026) · RSC Pharmaceutics · doi:10.1039/d5pm00263j
Preparação e caracterização de micro/nanopartículas de quitosano para
Martins, S. P. (2013)
Extracción, caracterización y valoración de genipina a partir del fruto de la Genipa Americana
Ochoa, G. Á. (2013) · Biblioteca Digital - Universidad Icesi
Harnessing genipin as a biocompatible crosslinker in nanomedicine for oncology applications
Sharma, T., Kaur, S., Sharma, J. B., Wahab, S., & Kapoor, D. U. (2026) · 3 Biotech · doi:10.1007/s13205-026-04791-2 · Cited by 1
“This prolongs drug circulation time and enhances therapeutic efficacy against tumors(Harris et al. 2010).”
Suner, S. C., ORAL, A., Al, A. M., Kahraman, E., & Yıldırım, Y. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115212
Metadata
- Authors
- Harris, R., Lecumberri, E., & Heras, A.
- Affiliations
- Universidad Complutense de Madrid (ES)
- Instituto de Estudios Biofuncionales, Departamento Química-Física II. Universidad Complutense Paseo Juan XXIII, 128040, Madrid, Spain
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2010-05-26
- Volume
- 8
- Issue
- 6
- Pages
- 1750-1762
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC2901822
- OpenAlex
- W2021771642
- Cited by
- 79
- References
- 24
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 1 · 2020: 6 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 12 · 2012: 3
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- chitosan microspheres, genipin, crosslinking, controlled drug release, clarithromycin, tramadol, low molecular weight heparin, chemical crosslinking, crosslink density, in vitro release profile, drug loading
- MeSH terms
- Analgesics, Opioid, Anti-Bacterial Agents, Anticoagulants, Chemistry, Pharmaceutical, Cross-Linking Reagents, Delayed-Action Preparations, Diffusion, Heparin, Low-Molecular-Weight, Kinetics, Microscopy, Electron, Scanning, Microspheres, Osmolar Concentration, Particle Size, Surface Properties, Tramadol, X-Ray Diffraction, Clarithromycin, Iridoids, Chitosan, Iridoid Glycosides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.